Business Context and Reporting Period
Amprius Technologies, Inc. reported on September 13, 2022 through Kensington Capital Acquisition Corp. IV, its special-purpose acquisition company, regarding shareholder approval of the proposed business combination. The transaction included domestication from the Cayman Islands to Delaware, a name change to Amprius Technologies, Inc., issuance of common stock to Amprius stockholders, and approval of equity incentive and employee stock purchase plans.
Key Financial and Transaction Metrics
- Redemptions: Holders redeemed 16,517,276 Class A ordinary shares at approximately $10.01 per share, representing aggregate cash redemptions of approximately $165.3 million.
- Minimum cash condition: Amprius agreed to waive the minimum cash condition required for closing.
- Deferred underwriting commissions: Underwriters waived approximately $8.1 million of deferred underwriting fees. The original IPO underwriting discount was approximately $4.6 million.
- Public float: The sponsor planned to distribute 13,124,642 common shares to its owners. Of those shares, 8,627,500 were expected to qualify for NYSE public-float calculations.
- Operating metrics: The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures for Amprius.
Material Changes Versus the Prior Comparable Period
This filing is a transaction and shareholder-vote report rather than an operating or periodic financial report. It does not present comparative financial statements or quantify changes in revenue, earnings, cash flow, margins, debt, or liquidity.
- Shareholders approved all submitted transaction-related proposals, including the business combination, domestication, charter amendment, NYSE share issuance, 2022 Equity Incentive Plan, and 2022 Employee Stock Purchase Plan.
- The business combination was expected to close on September 14, 2022.
- The combined company’s common stock and public warrants were expected to begin trading on the NYSE on September 15, 2022 under the symbols AMPX and AMPX.W, respectively.
Guidance, Outlook, Risks, and Unusual Items
Management did not provide operating or financial guidance in this filing. The principal outlook was the anticipated completion of the business combination and commencement of trading under the Amprius name.
Forward-looking statements are subject to risks including failure or delay in closing the transaction, regulatory or shareholder approval issues, failure to realize anticipated transaction benefits, timing of business milestones, competition, shortages of production materials, changes to clean-energy or electric-vehicle incentives, delays in production-facility construction and operation, additional redemption requests, and limited ability to raise equity or equity-linked capital.
UBS Securities LLC confirmed that it had resigned and was not acting as an underwriter for the transaction. The filing also notes that the high level of redemptions reduced the transaction’s available cash and that the minimum cash condition was waived.
Investor Verification Checklist
- Verify that the business combination closed as expected on September 14, 2022 and that the securities began trading under the stated AMPX and AMPX.W symbols.
- Confirm final post-closing cash, shares outstanding, public float, ownership structure, and any additional financing.
- Review the impact of approximately $165.3 million of redemptions on operating liquidity and capitalization.
- Confirm the final treatment of the waived minimum cash condition and any related amendments to the transaction agreement.
- Review subsequent filings for Amprius’s revenue, losses, cash usage, debt, production capacity, customer commitments, and progress toward commercialization.
- Assess dilution from sponsor shares, warrants, equity compensation plans, and any future equity or equity-linked issuance.